Senopsys

Senopsys is a biotechnology startup founded in 2006, dedicated to developing palatable drug products. The company's slogan "Dedicated to Developing Palatable Drug Products" reflects its commitment to enhancing patient compliance and health outcomes. Senopsys offers specialty services aimed at assisting in the development of new products, compliance with regulatory requirements such as the US Pediatric Research Equity Act (PREA) and EU Pediatric Investigation Plans, and product lifecycle management.

The firm utilizes GCP-compliant taste assessment tools to identify taste attributes of APIs and drug products, measure flavor quality of prototypes, and guide taste masking and optimization. Senopsys' experienced formulation scientists specialize in taste masking, flavor construction, excipient functionality, and processing technology to develop palatable liquid, powder, and solid dosage forms of investigational and approved drugs.

With its focus on Biotechnology, Care Economy, Health and Wellness, Life Sciences, and Pharmaceutical industries, Senopsys occupies a crucial niche in the healthcare sector. Although specific details regarding its headquarters, last investment, and last investment investors are not available, the company's dedication to improving the palatability of drug products contributes significantly to the healthcare and pharmaceutical landscape.